MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. achieved a net profit attributable to the parent company of 4.98 billion yuan in 2024, an increase of 1.1% year-on-year.
MicroPort Medical (00853) releases the performance of HeartRhythm Medical Technology for the 12 months ending December 31, 2024, with revenues...
MICROPORT(00853) announced the performance of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. for the 12 months ending on December 31, 2024. The revenue was 1.206 billion yuan, an increase of 1.6% compared to the previous year. The net profit attributable to the equity holders of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. was 498 million yuan, an increase of 1.1% compared to the previous year.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


